Doxiciclin-TEVA (doxycycline) tablets 100 mg. №10

$14.00

Manufacturer: Ukraine

Purpose: Inhibits bacterial protein synthesis, treats bacterial infections like acne and respiratory infections.

SKU: MED57978 Category:

Description

Doxiciclin-TEVA (doxycycline) tablets 100 mg. №10

Ingredients

Active ingredient: Doxycycline 100 mg per tablet.

Dosage

Dosage: The usual dosage is 100 mg to 200 mg daily in divided doses.

Indications

Indications: Doxycycline is indicated for the treatment of various infections caused by susceptible strains of bacteria.

Contraindications

Contraindications: Do not use in individuals with a known hypersensitivity to doxycycline or other tetracyclines.

Directions

Directions: Take this medication as prescribed by your healthcare provider. Do not take more than the recommended dose.

Scientific Evidence

Doxycycline, the active ingredient in Doxiciclin-TEVA tablets, is a broad-spectrum antibiotic that inhibits bacterial protein synthesis. Studies have shown its efficacy in treating various infections, including respiratory tract infections, urinary tract infections, and skin infections. Research published in the Journal of Antimicrobial Chemotherapy demonstrated doxycycline’s effectiveness against a wide range of pathogens, making it a valuable option in the treatment of bacterial infections.

Additional Information

It is important to complete the full course of doxycycline as prescribed, even if symptoms improve before the medication is finished. Doxycycline may interact with certain medications, so inform your healthcare provider about all the drugs you are taking before starting this treatment.

Pharmacological Effects: Doxycycline works by inhibiting bacterial protein synthesis, thus preventing the growth and spread of bacteria in the body. It is effective against a wide range of gram-positive and gram-negative bacteria, as well as certain other microorganisms.

Clinical Trials: Clinical trials have demonstrated the efficacy of doxycycline in treating various infections, with favorable outcomes and a good safety profile. A study published in the International Journal of Infectious Diseases showed that doxycycline was highly effective in the treatment of community-acquired pneumonia, highlighting its role as a first-line antibiotic in such cases.